McGurk Christopher J's Form 4/A amendment
AmendedCineverse Corp. (CNVS) · filed Aug 21, 2023
- Accession no.
- 0000950170-23-043750
- Filed
- Aug 21, 2023
- Trade date
- Aug 17-18, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Aug 21, 2023
This filing lists 2 non-derivative transactions. Open-market purchases total $100.1K. It was filed 4 days after the trade.
This amendment replaces 0000950170-23-043658 (filed Aug 21, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McGurk Christopher JCIK 0001190283 | Director, Officer (CEO and Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.03 to $1.16, inclusive. The reporting person undertakes to provide Cineverse Corp., any security holder of Cineverse Corp. or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F2
The reporting person is a trustee of the Christopher and Jamie McGurk Living Trust.
- F3
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.165 to $1.37, inclusive. The reporting person undertakes to provide Cineverse Corp., any security holder of Cineverse Corp. or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Remarks
This amendment is filed to revise information in Column 3 and the footnotes.